Unlock instant, AI-driven research and patent intelligence for your innovation.

Mitochondrial DNA deletion between about residues 12317-16254 for use in detection of cancer

An individual, breast cancer technology, used in recombinant DNA technology, DNA/RNA fragments, determination/examination of microorganisms, etc.

Inactive Publication Date: 2014-02-12
MDNA LIFE SCI
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although certain mtDNA alterations have been previously linked to breast cancer, e.g., as described in Parrella et al. (Cancer Research: 61, 2001), there is a need for additional markers for the detection of breast cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mitochondrial DNA deletion between about residues 12317-16254 for use in detection of cancer
  • Mitochondrial DNA deletion between about residues 12317-16254 for use in detection of cancer
  • Mitochondrial DNA deletion between about residues 12317-16254 for use in detection of cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0104] Example 1: Relationship between prostate cancer and 4kb deletion in human mtDNA

[0105] Urine samples were collected from 5 patients who had been diagnosed with prostate cancer and from 5 patients whose prostate malignancies were not detected by needle biopsy methods. These samples were collected following a digital rectal examination (DRE) to facilitate the collection of prostate cells.

[0106] Once the sample was obtained, a 5ml aliquot was removed and the 2ml sample was centrifuged at 14000 xg to pellet. Remove and discard supernatant.

[0107] Resuspend the pellet in 200 μl phosphate-buffered saline. DNA extraction procedures were performed on resuspended pellets and whole urine samples using the QiaAMP DNA Mini Kit (Qiagen P / N 51304) according to the manufacturer's instructions. The resulting DNA extracts were then quantified using a NanoDropND-1000 spectrophotometer and normalized to a concentration of 0.1 ng / μl.

[0108] Samples were analyzed by quantitative ...

Embodiment 2

[0143] Example 2: Relationship between 4kb deletion in human mtDNA and breast cancer

[0144] Of the 20 breast tissue samples collected, 10 were malignant and the other 10 had benign breast disease or no abnormalities. These samples were embedded in formalin-fixed paraffin, then individually cut into 20 micron sections into individual sample tubes and extracted according to the manufacturer's protocol of the QiaAMP DNA Mini Kit (Qiagen P / N 51304). DNA was then quantified using NanoDrop ND-1000 and normalized to a concentration of 2 ng / μl.

[0145] The level of the 4 kb deletion in the samples was then determined by quantitative real-time PCR using the following protocol.

[0146] X iQ SYBR Green Supermix (Bio-Rad product number: 170-8880)

[0147] 175nmol forward primer (5'-TTGGTGCAACTCCAAAGCCACCCCTCACC-3') (SEQ ID NO: 4)

[0148] 175nmol reverse primer (5'-AGGATGGTGGTCAAGGGAC-3') (SEQ ID NO: 5)

[0149] 25μl reaction solution containing 20ng template DNA

[0150] Reactio...

Embodiment 3

[0174] Example 3: Association of Prostate Cancer with 4kb Deletions in Human mtDNA Using Needle Biopsy Samples

[0175] Prostate needle biopsy samples were obtained from 19 individuals, 9 without prostate cancer and 10 with prostate cancer. Needle biopsies were formalin-fixed paraffin-embedded (FFPE) as is standard in clinical diagnostic settings. A 10 micron section of each biopsy was placed directly into a centrifuge tube and DNA was extracted using the QiaAMP DNA Mini kit (Qiagen, p / n 51306). DNA extracts were quantified using a NanoDrop ND-1000 spectrophotometer at 260 nm. Yields ranged from 347ng to 750ng. Dilute these samples to 2ng / μl and set up the amplification reaction according to Table 9 and the following:

[0176] Table 9: Reagents and concentrations for amplification reactions

[0177]

[0178]Add nuclease-free water to a final reaction volume of 25 µl. Amplification was performed on a DNA Engine Chromo4 real-time PCR instrument (Bio-Rad Laboratories) acc...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The present invention relates to methods for predicting, diagnosing and monitoring cancer. The methods comprise obtaining biological samples, extracting mitochondrial DNA (mtDNA) from the samples, quantifying a mtDNA mutation in the sample and comparing the level of the mtDNA mutation present in the sample with a reference value The methods of the invention may also be effective in screening for new therapeutic agents and treatment regimes Further, said methods may be also be useful for monitoring the response of a subject to a preventative or therapeutic treatment.

Description

[0001] Cross References to Related Applications [0002] This patent application claims priority to US Patent Application No. 60 / 002637, filed November 9, 2007, the entire contents of which are incorporated herein by reference. technical field [0003] The present invention relates to the field of mitochondrial genomes. In particular, it relates to the detection of mutations in the human mitochondrial genome and their use as cancer indicators. Background technique [0004] Mitochondrial DNA as a diagnostic tool [0005] Mitochondrial DNA (mtDNA) sequence dynamics are important diagnostic tools. Mutations in mtDNA are often initial indicators of disease development, often associated with nuclear mutations and used as biomarkers, specifically: diseases such as, but not limited to, tissue damage and cancer due to smoking and exposure to secondhand smoke ( Lee et al., 1998; Wei 1998); lifespan, which is based on the accumulation of mutations in the mitochondrial genome starti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/68C12P19/34C12N15/11
CPCC12Q2600/156C12Q1/6886C12Q1/6851C12Q2600/158
Inventor 瑞安·帕尔珍妮弗·克里德凯丽·鲁滨逊安德烈亚·马格格拉卡特里娜·马基加布里埃尔·达库波布赖恩·赖古伊安德鲁·哈博特尔祖德·亚历山大
Owner MDNA LIFE SCI